```html

AV (Atrioventricular) Block – Comprehensive Medical Guide

Overview

What is it? An atrioventricular (AV) block is a type of heart‑block in which the electrical impulses that travel from the atria (the heart’s upper chambers) to the ventricles (the lower chambers) are delayed or completely stopped. This interruption disrupts the normal timing of heartbeats, which can range from mild and asymptomatic to life‑threatening.

Types of AV block are classified by severity:

• First‑degree AV block – PR interval >200 ms but all impulses eventually reach the ventricles.
• Second‑degree AV block – Some atrial impulses fail to conduct. It is further divided into:
  • Mobitz Type I (Wenckebach) – progressively lengthening PR interval until a beat is dropped.
  • Mobitz Type II – abrupt dropped beats without PR prolongation.
• Third‑degree (complete) AV block – No atrial impulses reach the ventricles; the ventricles generate their own slower rhythm.

Who it affects? AV block can occur at any age, but the epidemiology varies by type:

• First‑degree block: seen in up to 1 % of the general population; prevalence increases with age, reaching 10 % in people >80 years.
• Second‑degree (Mobitz I): more common in young, healthy individuals and athletes.
• Second‑degree (Mobitz II) and third‑degree block: most often diagnosed in adults ≥60 years, frequently linked to structural heart disease.

In the United States, approximately 300,000 permanent pacemaker implantations are performed each year, many of which are for symptomatic AV block (National Heart, Lung, & Blood Institute, 2022).

Symptoms

Symptoms depend on the block’s grade and the heart’s ability to compensate. Below is a comprehensive list:

First‑Degree AV Block

• Usually asymptomatic – most patients discover it incidentally on an ECG.
• Occasional fatigue or mild exertional shortness of breath (rare).

Second‑Degree AV Block – Mobitz Type I (Wenckebach)

• Light‑headedness or dizziness, especially during exertion.
• Palpitations (feelings of “skipped” beats).
• Fatigue.
• Rarely, syncope (fainting) if ventricular rate becomes too slow.

Second‑Degree AV Block – Mobitz Type II

• Sudden syncope or near‑syncope.
• Marked fatigue, weakness.
• Chest discomfort or mild angina (if underlying coronary disease exists).
• Palpitations.

Third‑Degree (Complete) AV Block

• Frequent fainting episodes (often the first sign).
• Severe fatigue, inability to exercise.
• Dizziness, light‑headedness.
• Shortness of breath, especially when lying flat.
• Chest pain or pressure (if heart muscle is ischemic).
• Confusion or “brain fog” from low cardiac output.

Any new, unexplained fainting, chest pain, or severe shortness of breath should prompt immediate medical evaluation.

Causes and Risk Factors

AV block results from anything that interferes with the conduction tissue (the AV node, His bundle, or the Purkinje system). Common causes and risk factors include:

• Degenerative disease of the conduction system – age‑related fibrosis or calcification (most common in elderly patients).
• Ischemic heart disease – coronary artery blockage can damage the AV node, especially inferior myocardial infarctions.
• Cardiomyopathies – dilated or hypertrophic cardiomyopathy can involve the conduction pathways.
• Congenital heart defects – e.g., congenital AV block associated with maternal anti‑Ro/La antibodies.
• Inflammatory or infiltrative diseases – Lyme disease, sarcoidosis, amyloidosis.
• Medications – beta‑blockers, calcium‑channel blockers, digoxin, and certain antiarrhythmics (e.g., amiodarone, quinidine).
• Electrolyte abnormalities – hyperkalemia, severe hypocalcemia.
• Heart surgery or invasive cardiac procedures – damage to the conduction system during valve replacement or ablation.
• Autoimmune conditions – maternal antibodies crossing placenta (in neonates).

Risk factors increase the likelihood of developing an AV block:

• Age > 60 years.
• History of myocardial infarction, especially inferior wall.
• Cardiac surgery (especially aortic or mitral valve procedures).
• Chronic use of AV‑node‑blocking drugs.
• Family history of conduction disease.
• Systemic illnesses such as sarcoidosis or Lyme disease.

Diagnosis

Diagnosis is based on a combination of clinical evaluation and objective testing.

1. History & Physical Examination

• Assess timing and triggers of symptoms (e.g., exertion, medication changes).
• Check for signs of underlying heart disease: murmurs, gallops, peripheral edema.

2. Electrocardiogram (ECG)

The primary tool. Key findings:

• First‑degree: PR interval >200 ms.
• Mobitz I: progressive PR prolongation with a dropped QRS.
• Mobitz II: constant PR interval with intermittent non‑conducted P waves.
• Third‑degree: AV dissociation – P waves and QRS complexes independent of each other.

3. Ambulatory Monitoring

• Holter monitor (24‑48 h) – captures intermittent blocks.
• Event recorder or implantable loop recorder – for infrequent symptoms.

4. Exercise Stress Test

Especially useful for Mobitz I to see if block worsens with exertion.

5. Electrophysiology Study (EPS)

Invasive mapping of the conduction system, reserved for ambiguous cases or when planning complex ablation.

6. Laboratory Tests

• Electrolytes, renal function, thyroid panel (to rule out reversible causes).
• Serology for Lyme disease or sarcoidosis if clinically indicated.

7. Imaging

• Echocardiogram – evaluates structural heart disease, ventricular function.
• Cardiac MRI – helpful for infiltrative diseases (e.g., sarcoidosis, amyloidosis).

Treatment Options

Treatment is individualized based on block severity, symptoms, and underlying cause.

1. Identify & Treat Reversible Causes

• Discontinue or adjust AV‑node‑blocking medications.
• Correct electrolyte abnormalities (e.g., treat hyperkalemia).
• Antibiotic therapy for Lyme disease.
• Immunosuppression for sarcoidosis or other inflammatory conditions.

2. Pharmacologic Management

Medications rarely reverse a high‑grade block but may be used to control rate in certain scenarios:

• Atropine (IV) – short‑term increase in AV nodal conduction in emergency settings.
• Isoproterenol infusion – temporary bridge to pacing.
• Beta‑blocker or calcium‑channel blocker withdrawal if they are the precipitating factor.

3. Cardiac Pacing

Permanent pacing is the definitive therapy for symptomatic Mobitz II, third‑degree block, and many symptomatic first‑degree blocks in the elderly.

• Transvenous (temporary) pacing – used in emergencies while awaiting permanent device.
• Permanent pacemaker (PPM) – most commonly a dual‑chamber device (DDD) that paces both atrium and ventricle, preserving AV synchrony.
• Leadless pacemakers (e.g., Micra) are an option for patients without a need for atrial pacing.

4. Lifestyle and Supportive Measures

• Limit activities that provoke symptoms until evaluated.
• Educate about medication interactions (e.g., avoid over‑the‑counter decongestants that contain pseudoephedrine).
• Regular follow‑up with cardiology; device checks every 6‑12 months.

Living with AV (atrioventricular) Block

Adapting daily life helps maintain quality of life and reduces complications.

• Medication awareness – keep an updated list; inform pharmacists and physicians about your conduction disorder.
• Physical activity – most patients can exercise once cleared by a cardiologist. Low‑impact aerobic activities (walking, swimming) are usually safe.
• Monitor heart rate – some patients use wearable devices; report sustained heart rates <50 bpm or >120 bpm to your doctor.
• Travel precautions – carry a medical alert card or bracelet noting “AV block – pacemaker in place,” and bring a portable charger for the device if you have a leadless system.
• Vaccinations – flu and COVID‑19 vaccines reduce the risk of infections that could precipitate electrolyte disturbances.
• Emergency plan – have a protocol (call 911, inform EMS of pacemaker) and a copy of your device interrogation report.

Prevention

While you cannot eliminate all causes (e.g., congenital block), several strategies lower the risk of developing a high‑grade AV block:

• Control cardiovascular risk factors: hypertension, diabetes, hyperlipidemia – these reduce atherosclerotic disease that can involve the AV node.
• Avoid unnecessary use of AV‑node‑blocking drugs; discuss alternatives with your physician.
• Prompt treatment of infections such as Lyme disease, especially after tick bites in endemic areas.
• Regular cardiac check‑ups after heart surgery or myocardial infarction.
• Maintain electrolyte balance; stay hydrated and have periodic labs if you have chronic kidney disease.

Complications

If an AV block is not recognized or treated appropriately, serious complications may arise:

• Syncope and falls – can lead to traumatic injuries, especially in older adults.
• Heart failure – prolonged bradycardia reduces cardiac output, precipitating or worsening systolic dysfunction.
• Sudden cardiac death – especially in Mobitz II and complete block without a safety net of a pacemaker.
• Thromboembolic events – low cardiac output can promote stasis in the atria, increasing stroke risk (more relevant in associated atrial arrhythmias).
• Pacemaker‑related complications – infection, lead fracture, or device malfunction, though rare, require prompt attention.

When to Seek Emergency Care

References

1. Mayo Clinic. “Heart block.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/heart-block/symptoms-causes/syc-20353044
2. National Heart, Lung, & Blood Institute. “Pacemaker and Implantable Cardioverter‑Defibrillator.” 2022. https://www.nhlbi.nih.gov/health-topics/pacemaker
3. Cleveland Clinic. “Atrioventricular (AV) Block.” 2023. https://my.clevelandclinic.org/health/diseases/17044-atrial-and-ventricular-heart-block
4. American Heart Association. “Understanding Heart Block.” 2022. https://www.heart.org/en/health-topics/arrhythmia/about-arrhythmia/understanding-heart-block
5. World Health Organization. “Cardiovascular diseases (CVDs) Fact Sheet.” 2021. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

```